-
into biologically and clinically meaningful subgroups is expected to improve diagnosis, disease management, and therapeutic development. The collaborative PhD project, co-hosted by the Rademakers and Sleegers labs
-
. The project begins with bladder cancer detection from urine-derived DNA and expands towards a broader set of urologic and related cancers, ultimately supporting precision diagnostics from urine to clinic
-
project focuses on high-risk individuals and PD patients and aims to identify circulating immune signatures that anticipate disease onset and progression. Our lab studies how peripheral immunity shapes
-
reflect early Parkinson’s disease (PD) biology. The project focuses on high-risk individuals and PD patients and aims to identify circulating immune signatures that anticipate disease onset and progression